In line with the oncogenic function of TMEM65, targeting depletion of TMEM65 by VNP-encapsulated TMEM65-siRNA significantly suppressed tumor growth in subcutaneous xenograft tumor model, and TMEM65 could serve as a therapeutic target in GC. Here, TMEM65 is linked to gastric cancer.